135 related articles for article (PubMed ID: 14582847)
21. The relationship between the antitumor activity and the ribonucleotide reductase inhibitory activity of (E)-2'-deoxy-2'-(fluoromethylene) cytidine, MDL 101,731.
Kanazawa J; Takahashi T; Akinaga S; Tamaoki T; Okabe M
Anticancer Drugs; 1998 Aug; 9(7):653-7. PubMed ID: 9773810
[TBL] [Abstract][Full Text] [Related]
22. Synergistic reduction of HIV-1 infectivity by 5-azacytidine and inhibitors of ribonucleotide reductase.
Rawson JMO; Roth ME; Xie J; Daly MB; Clouser CL; Landman SR; Reilly CS; Bonnac L; Kim B; Patterson SE; Mansky LM
Bioorg Med Chem; 2016 Jun; 24(11):2410-2422. PubMed ID: 27117260
[TBL] [Abstract][Full Text] [Related]
23. Nucleoside 5'-diphosphates as effectors of mammalian ribonucleotide reductase.
Cory JG; Rey DA; Carter GL; Bacon PE
J Biol Chem; 1985 Oct; 260(22):12001-7. PubMed ID: 3900066
[TBL] [Abstract][Full Text] [Related]
24. Design and virtual screening towards synthesis of novel substituted thiosemicarbozones as ribonuleotide reductase (RNR) inhibitors with improved cellular trafficking and anticancer activity.
Gokhale N; Jain S; Yadav M
Curr Top Med Chem; 2015; 15(1):37-42. PubMed ID: 25579572
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and cytotoxicity of 9-(2-deoxy-2-alkyldithio-beta-D-arabinofuranosyl)purine nucleosides which are stable precursors to potential mechanistic probes of ribonucleotide reductases.
Wnuk SF; Lewandowska E; Companioni DR; Garcia PI; Secrist JA
Org Biomol Chem; 2004 Jan; 2(1):120-6. PubMed ID: 14737670
[TBL] [Abstract][Full Text] [Related]
26. Some new acyclic nucleotide analogues as antiviral prodrugs: synthesis and bioactivities in vitro.
Tang YB; Peng ZG; Liu ZY; Li YP; Jiang JD; Li ZR
Bioorg Med Chem Lett; 2007 Nov; 17(22):6350-3. PubMed ID: 17888662
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and antiviral evaluation of novel 4'-hydroxymethyl branched apiosyl nucleosides.
Kim JW; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2006; 25(1):109-17. PubMed ID: 16440989
[TBL] [Abstract][Full Text] [Related]
28. Studies on mammalian ribonucleotide reductase inhibition by pyridoxal phosphate and the dialdehyde derivatives of adenosine, adenosine 5'-monophosphate, and adenosine 5'-triphosphate.
Cory JG; Mansell MM
Cancer Res; 1975 Feb; 35(2):390-6. PubMed ID: 1109803
[TBL] [Abstract][Full Text] [Related]
29. Ribonucleotide reductase: a critical enzyme for cancer chemotherapy and antiviral agents.
Cerqueira NM; Fernandes PA; Ramos MJ
Recent Pat Anticancer Drug Discov; 2007 Jan; 2(1):11-29. PubMed ID: 18221051
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of unsaturated keto and exomethylene D-arabinopyranonucleoside analogs: novel 5-fluorouracil analogs that target thymidylate synthase.
Tzioumaki N; Manta S; Tsoukala E; Vande Voorde J; Liekens S; Komiotis D; Balzarini J
Eur J Med Chem; 2011 Apr; 46(4):993-1005. PubMed ID: 21330014
[TBL] [Abstract][Full Text] [Related]
31. Structure-guided design of anti-cancer ribonucleotide reductase inhibitors.
Misko TA; Liu YT; Harris ME; Oleinick NL; Pink J; Lee HY; Dealwis CG
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):438-450. PubMed ID: 30734609
[TBL] [Abstract][Full Text] [Related]
32. Phototriggerable peptidomimetics for the inhibition of Mycobacterium tuberculosis ribonucleotide reductase by targeting protein-protein binding.
Karlsson C; Blom M; Johansson M; Jansson AM; Scifo E; Karlén A; Govender T; Gogoll A
Org Biomol Chem; 2015 Mar; 13(9):2612-21. PubMed ID: 25580895
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antiviral activity of (Z)- and (E)-2,2-[bis(hydroxymethyl)cyclopropylidene]methylpurines and -pyrimidines: second-generation methylenecyclopropane analogues of nucleosides.
Zhou S; Breitenbach JM; Borysko KZ; Drach JC; Kern ER; Gullen E; Cheng YC; Zemlicka J
J Med Chem; 2004 Jan; 47(3):566-75. PubMed ID: 14736238
[TBL] [Abstract][Full Text] [Related]
34. Structure-based design and synthesis of substituted 2-butanols as nonpeptidic inhibitors of HIV protease: secondary amide series.
Reich SH; Melnick M; Pino MJ; Fuhry MA; Trippe AJ; Appelt K; Davies JF; Wu BW; Musick L
J Med Chem; 1996 Jul; 39(14):2781-94. PubMed ID: 8709109
[TBL] [Abstract][Full Text] [Related]
35. Affinity labeling of ribonucleotide reductase by the 2',3'-dialdehyde derivatives of ribonucleotides.
Tsai PK; Hogenkamp HP
Arch Biochem Biophys; 1983 Oct; 226(1):276-84. PubMed ID: 6357087
[TBL] [Abstract][Full Text] [Related]
36. Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase with improved in vivo antiviral activity.
Moss N; Beaulieu P; Duceppe JS; Ferland JM; Garneau M; Gauthier J; Ghiro E; Goulet S; Guse I; Jaramillo J; Llinas-Brunet M; Malenfant E; Plante R; Poirier M; Soucy F; Wernic D; Yoakim C; Déziel R
J Med Chem; 1996 Oct; 39(21):4173-80. PubMed ID: 8863795
[TBL] [Abstract][Full Text] [Related]
37. Ribonucleotide reductase inhibition by p-alkoxyphenols studied by molecular docking and molecular dynamics simulations.
Luo J; Gräslund A
Arch Biochem Biophys; 2011 Dec; 516(1):29-34. PubMed ID: 21951815
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and bioactivity of novel inhibitors of E. coli aspartate transcarbamoylase.
Eldo J; Heng S; Kantrowitz ER
Bioorg Med Chem Lett; 2007 Apr; 17(7):2086-90. PubMed ID: 17336518
[TBL] [Abstract][Full Text] [Related]
39. Discovery of antimicrobial ribonucleotide reductase inhibitors by screening in microwell format.
Tholander F; Sjöberg BM
Proc Natl Acad Sci U S A; 2012 Jun; 109(25):9798-803. PubMed ID: 22665797
[TBL] [Abstract][Full Text] [Related]
40. Substrate specificity of human ribonucleotide reductase from Molt-4F cells.
Chang CH; Cheng YC
Cancer Res; 1979 Dec; 39(12):5081-6. PubMed ID: 498135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
